1. Role of protein arginine methyltransferase 5 in human cancers
   Wendi Xiao et al, 2019, Biomedicine & Pharmacotherapy CrossRef
2. Protein Arginine Methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K Pathways: A Case for PRMT5 Inhibition and Combination Therapies in Cancer
   Tzuriel Sapir et al, 2021, Molecular Cancer Research CrossRef
3. E3 ubiquitin ligases in nasopharyngeal carcinoma and implications for therapies
   Zijian Zhou et al, 2023, Journal of Molecular Medicine CrossRef
4. The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck
   Vassiliki Saloura et al, 2018, Oral Oncology CrossRef
5. Protein Post-translational Modifications in Head and Neck Cancer
   Hongbo Zhang et al, 2020, Frontiers in Oncology CrossRef
6. Cullin 4A/protein arginine methyltransferase 5 (CUL4A/PRMT5) promotes cell malignant phenotypes and tumor growth in nasopharyngeal carcinoma
   Xiuying Sun et al, 2022, Bioengineered CrossRef
7. Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer
   Harshita Shailesh et al, 2018, Oncotarget CrossRef
8. The uncharacterized protein FAM47E interacts with PRMT5 and regulates its functions
   Baskar Chakrapani et al, 2021, Life Science Alliance CrossRef
9. Clinicopathological and Prognostic Significance of PRMT5 in Cancers: A System Review and Meta-Analysis
   Zhenzhen Liang et al, 2021, Cancer Control CrossRef
10. Targeting protein arginine methyltransferase 5 in disease
    André Richters, 2017, Future Medicinal Chemistry CrossRef
11. Serum glycine dehydrogenase is associated with increased risk of lung cancer and promotes malignant transformation by regulating DNA methyltransferases expression
    Hai‑Yan Wei et al, 2018, Molecular Medicine Reports CrossRef